Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

Press releases published on May 21, 2026

May 21, 2026

The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do

Indeterminate GlobeNewswire

May 21, 2026

Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes

Indeterminate GlobeNewswire

May 21, 2026

Vitacore Announces World-First Custom-Fit CPAP Mask Following Health Canada MDL Approval

Indeterminate GlobeNewswire

May 21, 2026

Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with “All-in-at-10” Community-Focused Celebrations May 21st-May 30th

Indeterminate GlobeNewswire

May 21, 2026

Picard Medical / SynCardia Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 21, 2026

Hemab Therapeutics Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 21, 2026

Materials Industry Sees $216 Billion in Strategic Investments as AI Infrastructure Drives Next-Generation Material Innovation

Indeterminate GlobeNewswire

May 21, 2026

Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

May 21, 2026

Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma

Indeterminate GlobeNewswire

May 21, 2026

SlimTide Examined: 2026 Consumer-Focused Analysis of Ingredients, Claims, and Label Transparency

Indeterminate GlobeNewswire

May 21, 2026

JavaTide Examined: 2026 Analysis of Ingredients Profile, Dosage Accuracy, and Metabolic Support Claims

Indeterminate GlobeNewswire

May 21, 2026

Biodesix to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 21, 2026

Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2

Indeterminate GlobeNewswire

May 21, 2026

HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma

Indeterminate GlobeNewswire

May 21, 2026

Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia

Indeterminate GlobeNewswire

May 21, 2026

Concept Life Sciences Partners with OpenBench to Deliver Success-Based Drug Discovery Services for Early-Stage Biotech

Indeterminate GlobeNewswire

May 21, 2026

Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting

Indeterminate GlobeNewswire

May 21, 2026

Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026 ASCO®-vuosikokouksessa

Indeterminate GlobeNewswire

May 21, 2026

Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris

Indeterminate GlobeNewswire

May 21, 2026

Nanobiotix annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire